152 related articles for article (PubMed ID: 26333256)
1. FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study.
Reilmann R; Lippross V; Hölzner E; Gigengack F; Bohlen S; Kugel H; Deppe M; Osada N; Lücke M; Riess O; Nguyen HP; Von Hörsten S; Schäfers K; Schäfers M; Jacobs AH; Hermann S
J Huntingtons Dis; 2015; 4(1):37-47. PubMed ID: 26333256
[TBL] [Abstract][Full Text] [Related]
2. Genotype specific age related changes in a transgenic rat model of Huntington's disease.
Blockx I; Van Camp N; Verhoye M; Boisgard R; Dubois A; Jego B; Jonckers E; Raber K; Siquier K; Kuhnast B; Dollé F; Nguyen HP; Von Hörsten S; Tavitian B; Van der Linden A
Neuroimage; 2011 Oct; 58(4):1006-16. PubMed ID: 21767653
[TBL] [Abstract][Full Text] [Related]
3. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
4. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
Casteels C; Vermaelen P; Nuyts J; Van Der Linden A; Baekelandt V; Mortelmans L; Bormans G; Van Laere K
J Nucl Med; 2006 Nov; 47(11):1858-66. PubMed ID: 17079820
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease.
Casteels C; Vandeputte C; Rangarajan JR; Dresselaers T; Riess O; Bormans G; Maes F; Himmelreich U; Nguyen H; Van Laere K
Exp Neurol; 2011 Jun; 229(2):440-9. PubMed ID: 21459091
[TBL] [Abstract][Full Text] [Related]
6. Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters.
López Mora DA; Sampedro F; Camacho V; Fernández A; Fuentes F; Duch J; Pérez-Perez J; Martínez-Horta S; Marín-Lahoz J; Domènech A; Flotats A; Estorch M; Kulisevsky J; Carrió I
Clin Nucl Med; 2019 Jan; 44(1):e1-e5. PubMed ID: 30325816
[TBL] [Abstract][Full Text] [Related]
7. Small-animal repetitive transcranial magnetic stimulation combined with [¹⁸F]-FDG microPET to quantify the neuromodulation effect in the rat brain.
Parthoens J; Verhaeghe J; Wyckhuys T; Stroobants S; Staelens S
Neuroscience; 2014 Sep; 275():436-43. PubMed ID: 24979056
[TBL] [Abstract][Full Text] [Related]
8. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Ciarmiello A; Cannella M; Lastoria S; Simonelli M; Frati L; Rubinsztein DC; Squitieri F
J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging of a minipig model of Huntington's disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessments.
Schubert R; Frank F; Nagelmann N; Liebsch L; Schuldenzucker V; Schramke S; Wirsig M; Johnson H; Kim EY; Ott S; Hölzner E; Demokritov SO; Motlik J; Faber C; Reilmann R
J Neurosci Methods; 2016 May; 265():46-55. PubMed ID: 26658298
[TBL] [Abstract][Full Text] [Related]
10. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
[TBL] [Abstract][Full Text] [Related]
11. Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
Klupp E; Grimmer T; Tahmasian M; Sorg C; Yakushev I; Yousefi BH; Drzezga A; Förster S
J Nucl Med; 2015 Mar; 56(3):399-404. PubMed ID: 25678488
[TBL] [Abstract][Full Text] [Related]
12. PET Imaging in Huntington's Disease.
Roussakis AA; Piccini P
J Huntingtons Dis; 2015; 4(4):287-96. PubMed ID: 26683130
[TBL] [Abstract][Full Text] [Related]
13. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
Feigin A; Leenders KL; Moeller JR; Missimer J; Kuenig G; Spetsieris P; Antonini A; Eidelberg D
J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
[TBL] [Abstract][Full Text] [Related]
14. Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction.
Hellem MNN; Vinther-Jensen T; Anderberg L; Budtz-Jørgensen E; Hjermind LE; Larsen VA; Nielsen JE; Law I
PLoS One; 2021; 16(6):e0252683. PubMed ID: 34115782
[TBL] [Abstract][Full Text] [Related]
15. Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease.
Kirch RD; Meyer PT; Geisler S; Braun F; Gehrig S; Langen KJ; von Hörsten S; Nikkhah G; Cassel JC; Döbrössy MD
Behav Brain Res; 2013 Feb; 239():15-26. PubMed ID: 23137697
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.
Delva A; Van Laere K; Vandenberghe W
Mov Disord; 2023 Aug; 38(8):1515-1526. PubMed ID: 37382295
[TBL] [Abstract][Full Text] [Related]
17. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
[TBL] [Abstract][Full Text] [Related]
18. Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
Delva A; Michiels L; Koole M; Van Laere K; Vandenberghe W
Neurology; 2022 Jan; 98(1):e83-e94. PubMed ID: 34663644
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT: an unexpected case of Huntington's disease.
Michels S; Buchholz HG; Rosar F; Heinrich I; Hoffmann MA; Schweiger S; Tüscher O; Schreckenberger M
BMC Neurol; 2019 May; 19(1):78. PubMed ID: 31043171
[TBL] [Abstract][Full Text] [Related]
20. Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.
Sampedro F; Martínez-Horta S; Perez-Perez J; Horta-Barba A; Lopez-Mora DA; Camacho V; Fernández-León A; Gomez-Anson B; Carrió I; Kulisevsky J
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1111-1116. PubMed ID: 30627816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
